200,000+ products from a single source!
sales@angenechem.com
145781-92-6 | 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-, 2-(aminocarbonyl)hydrazide, acetate (1:?)
CAS No: 145781-92-6 Catalog No: AG001DEH MDL No:
Product Description
Catalog Number:
AG001DEH
Chemical Name:
1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-, 2-(aminocarbonyl)hydrazide, acetate (1:?)
CAS Number:
145781-92-6
Molecular Formula:
C61H88N18O16
Molecular Weight:
1329.4624
IUPAC Name:
acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
InChI:
InChI=1S/C59H84N18O14.C2H4O2/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38;1-2(3)4/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90);1H3,(H,3,4)/t38-,39-,40-,41-,42-,43-,44-,45+,46-;/m0./s1
InChI Key:
IKDXDQDKCZPQSZ-JHYYTBFNSA-N
SMILES:
CC(=O)O.OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)CCCNC(=N)N)CC(C)C)COC(C)(C)C)Cc1ccc(cc1)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)Cc1nc[nH]c1
UNII:
6YUU2PV0U8
Properties
Complexity:
2590
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
9
Defined Bond Stereocenter Count:
0
Exact Mass:
1328.663g/mol
Formal Charge:
0
Heavy Atom Count:
95
Hydrogen Bond Acceptor Count:
18
Hydrogen Bond Donor Count:
18
Isotope Atom Count:
0
Molecular Weight:
1329.485g/mol
Monoisotopic Mass:
1328.663g/mol
Rotatable Bond Count:
32
Topological Polar Surface Area:
533A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Efficacy and safety investigation of Kuntai capsule for the add-back therapy of gonadotropin releasing hormone agonist administration to endometriosis patients: a randomized, double-blind, blank- and tibolone-controlled study. | Chinese medical journal 20150220 |
| Targeted androgen pathway suppression in localized prostate cancer: a pilot study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20140120 |
| Development of psychophysiological motoric reactivity is influenced by peripubertal pharmacological inhibition of gonadotropin releasing hormone action--results of an ovine model. | Psychoneuroendocrinology 20121101 |
| Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer. | Urologic oncology 20120901 |
| Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer. | European journal of cancer (Oxford, England : 1990) 20120901 |
| [Could gosereline acetate induce autoimmune-like hepatitis?]. | Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20120901 |
| New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist. | BJU international 20120801 |
| Goserelin versus leuprolide in the chemical castration of patients with prostate cancer. | International urology and nephrology 20120801 |
| Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. | International journal of radiation oncology, biology, physics 20120801 |
| [Prostate carcinoma with squamous differentiation after combination endocrine therapy: a case report]. | Hinyokika kiyo. Acta urologica Japonica 20120801 |
| Effects of bone-targeted agents on cancer progression and mortality. | Journal of the National Cancer Institute 20120718 |
| Chemical castration and anti-androgens induce differential gene expression in prostate cancer. | The Journal of pathology 20120701 |
| A Phase II trial of Zoladex combined with CEF chemotherapy as neoadjuvant therapy in premenopausal women with hormone-responsive, operable breast cancer. | Medical oncology (Northwood, London, England) 20120601 |
| The long-term results with delayed-combined androgen blockade therapy in local or locally advanced prostate cancer. | Japanese journal of clinical oncology 20120601 |
| UK guidance document: treatment of metastatic breast cancer. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20120401 |
| GnRH analogue use in postmenopausal hyperandrogenism: long-term remission. | Endocrine 20120401 |
| Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. | Acta obstetricia et gynecologica Scandinavica 20120401 |
| Aromatase inhibitors in premenopausal breast cancer. | The Lancet. Oncology 20120401 |
| Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial. | The Lancet. Oncology 20120401 |
| [Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women]. | Ceska gynekologie 20120401 |
| Phase II study of long-term androgen suppression with bevacizumab and intensity-modulated radiation therapy (IMRT) in high-risk prostate cancer. | International journal of radiation oncology, biology, physics 20120315 |
| DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study. | Magnetic resonance in medicine 20120301 |
| Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109. | Urology 20120301 |
| Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120210 |
| Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer. | BMC cancer 20120101 |
| Primary hormonal treatment in localized and locally advanced prostate cancer: effectiveness and survival predictive factors. | Acta medica Indonesiana 20120101 |
| Benign metastasising leiomyoma: a progressive disease despite chemical and surgical castration. | BMJ case reports 20120101 |
| Pregnancy a short time after multimodal therapy for bilateral breast cancer: a case report and review of literature. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20111201 |
| Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: a single institution experience. | International journal of clinical oncology 20111201 |
| Breast cancer in very young women. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20111201 |
| Follicle loss after laparoscopic treatment of ovarian endometriotic cysts. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20111201 |
| [Study on the effects of gonadotropin-releasing hormone analogues in the inhibition of ovarian cancer transplanted tumors and in the protection of ovarian function after chemotherapy on nude mice]. | Zhonghua fu chan ke za zhi 20111201 |
| Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20111001 |
| The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancer. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20111001 |
| Pemphigoid gestationis: current management. | Dermatologic clinics 20111001 |
| Oxidative stress and antioxidant status in prostate cancer patients: relation to Gleason score, treatment and bone metastasis. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20111001 |
| Effects of endurance training on combined goserelin acetate and doxorubicin treatment-induced cardiac dysfunction. | Cancer chemotherapy and pharmacology 20110901 |
| ZORO study: discrepancy between the conclusion and the results. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820 |
| Temporary ovarian suppression with goserelin and ovarian function protection in patients with breast cancer undergoing chemotherapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820 |
| Failure of ovarian ablation with goserelin in a pre-menopausal breast cancer patient resulting in pregnancy: a case report and review of the literature. | Breast cancer research and treatment 20110801 |
| Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer. | Breast cancer research and treatment 20110801 |
| [ RANKL antibody for treatment of cancer treatment-induced bone loss (CTIBL)]. | Clinical calcium 20110801 |
| Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. | JAMA 20110720 |
| Use of collision induced dissociation mass spectrometry as a rapid technique for the identification of pharmacologically active peptides in pharmacopoeial testing. | Journal of pharmaceutical and biomedical analysis 20110715 |
| Radiotherapy and short-term androgen deprivation for localized prostate cancer. | The New England journal of medicine 20110714 |
| Antivascular effects of neoadjuvant androgen deprivation for prostate cancer: an in vivo human study using susceptibility and relaxivity dynamic MRI. | International journal of radiation oncology, biology, physics 20110701 |
| Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110701 |
| Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110610 |
| Adenomyosis is a potential cause of recurrent implantation failure during IVF treatment. | The Australian & New Zealand journal of obstetrics & gynaecology 20110601 |
| [Effect of local cooling at injection site of goserelin acetate for pain relief]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110601 |
| Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110520 |
| Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. | The Lancet. Oncology 20110501 |
| Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer. | Breast cancer research and treatment 20110401 |
| The effects of androgen deprivation therapy on lipid metabolism and body composition in Japanese patients with prostate cancer. | Japanese journal of clinical oncology 20110401 |
| [Successful combined treatment with maximal androgen blockade (MAB), intra arterial chemotherapy and radiation for advanced prostatic ductal adenocarcinoma : report of two cases]. | Hinyokika kiyo. Acta urologica Japonica 20110401 |
| Anaphylactic reaction to different gonadotropin-releasing hormone agonists for the treatment of endometriosis. | The American journal of the medical sciences 20110301 |
| Editorial comment. | The Journal of urology 20110301 |
| Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrence. | The Journal of urology 20110301 |
| Breast cancer: adjuvant modalities. | Clinical obstetrics and gynecology 20110301 |
| Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20110201 |
| Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. | Fertility and sterility 20110201 |
| Depression related to (neo)adjuvant hormonal therapy for prostate cancer. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110201 |
| Prepubertal gonadotropin-releasing hormone analog leads to exaggerated behavioral and emotional sex differences in sheep. | Hormones and behavior 20110101 |
| Unexpected enlargement of clinically silent pituitary gonadotroph adenoma induced by goserelin acetate given as treatment for prostate cancer. | International journal of urology : official journal of the Japanese Urological Association 20110101 |
| Cost-benefit of laparoscopic versus medical ovarian suppression in premenopausal breast cancer. | The breast journal 20110101 |
| Resolution of catamenial epilepsy after goserelin therapy and oophorectomy: case report of presumed cerebral endometriosis. | Journal of minimally invasive gynecology 20110101 |
| Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20110101 |
| Evaluation of osteoporosis risk assessment in veterans receiving androgen-deprivation therapy. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110101 |
| Goserelin plus letrozole as first- or second-line hormonal treatment in premenopausal patients with advanced breast cancer. | Endocrine journal 20110101 |
| Recurrent episodes of recall dermatitis of irradiated breast after LHRH agonist administration. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101 |
| Evolution of pulmonary function after treatment with goserelin in patients with lymphangioleiomyomatosis. | Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20110101 |
| [The role of hormonal ovarian ablation in adjuvant treatment of premenopausal breast cancer]. | Srpski arhiv za celokupno lekarstvo 20110101 |
| [Impact of neoadjuvant hormonal therapy on the permanent ¹²⁵I-seed brachytherapy for localized high-risk prostate cancer]. | Zhonghua yi xue za zhi 20101228 |
| Medicare reimbursement and prescribing hormone therapy for prostate cancer. | Journal of the National Cancer Institute 20101215 |
| Timing of salvage hormonal therapy in prostate cancer patients with unfavorable prognosis treated with radiotherapy: a secondary analysis of Radiation Therapy Oncology Group 85-31. | International journal of radiation oncology, biology, physics 20101201 |
| Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3. | Prostate cancer and prostatic diseases 20101201 |
| Use of hormonal protection for chemotherapy-induced gonadotoxicity. | Clinical obstetrics and gynecology 20101201 |
| Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women. | European journal of cancer (Oxford, England : 1990) 20101101 |
| Combining luteinising hormone releasing hormone agonists and aromatase inhibitors in breast cancer. | European journal of cancer (Oxford, England : 1990) 20101101 |
| Adrenocorticotropic hormone is involved in regulation of androgen synthesis in men receiving androgen deprivation therapy for localized prostate cancer. | The Journal of urology 20101101 |
| External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. | The Lancet. Oncology 20101101 |
| Is long-term androgen suppression right for everyone with locally advanced prostate cancer? | The Lancet. Oncology 20101101 |
| Granulomas induced by subcutaneous injection of a luteinizing hormone-releasing hormone analog: a case report and review of the literature. | Journal of cutaneous pathology 20101001 |
| Effectiveness of skin icing in reducing pain associated with goserelin acetate injection. | International journal of clinical oncology 20101001 |
| Randomized comparison of goserelin versus suction curettage prior to Thermachoice II balloon endometrial ablation: one-year results. | Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20101001 |
| Latent class joint model of ovarian function suppression and DFS for premenopausal breast cancer patients. | Statistics in medicine 20100930 |
| Serum prostate-specific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy: Tumor malignant potential and androgen milieu. | The Prostate 20100915 |
| GnRH receptor and peritoneal plasmin activity. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20100901 |
| Delayed pituitary apoplexy in patient with advanced prostate cancer treated with gonadotrophin-releasing hormone agonists. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20100901 |
| The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial. | Human reproduction (Oxford, England) 20100901 |
| Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100901 |
| Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100815 |
| Genic expression of the uterine leiomyoma in reproductive-aged women after treatment with goserelin. | Fertility and sterility 20100801 |
| Management of thrombotic thrombocytopenic purpura in metastatic prostate cancer with only endocrine therapy. | Annals of the Academy of Medicine, Singapore 20100701 |
| Phase II parallel group study showing comparable efficacy between premenopausal metastatic breast cancer patients treated with letrozole plus goserelin and postmenopausal patients treated with letrozole alone as first-line hormone therapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100601 |
| Direct and indirect effects of kisspeptin on liver oxidant and antioxidant systems in young male rats. | Cell biochemistry and function 20100601 |
| Long term zoledronic acid during androgen blockade for prostate cancer. | The Canadian journal of urology 20100601 |
| [Can serum testosterone level measurement extend the intervals of administration of a long-acting LHRH agonist ?]. | Hinyokika kiyo. Acta urologica Japonica 20100601 |
| Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy. | Breast cancer research and treatment 20100501 |
| Metastatic breast carcinoma presenting with profound hypocalcemia. | Southern medical journal 20100501 |
| Permanent localized hair repigmentation following herpes zoster infection. | Archives of dermatology 20100501 |
| Effect of GnRH II and GnRH I on secretion of VEGF by eutopic and ectopic endometrial stromal cells of endometriosis patients. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20100501 |
| Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapy. | International journal of radiation oncology, biology, physics 20100401 |
| [Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis]. | Zhonghua fu chan ke za zhi 20100401 |
| [Goserelin plus anastrozole in the treatment of premenopausal patients with metastatic breast cancer]. | Zhonghua yi xue za zhi 20100302 |
| Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance? | BJU international 20100301 |
| Selection bias clouds apparent benefit of longer hormone duration. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100210 |
| A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog. | Psychoneuroendocrinology 20100201 |
| Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20100201 |
| Bone metabolic disorder in patients with prostate cancer receiving androgen deprivation therapy (ADT): impact of ADT on the growth hormone/insulin-like growth factor-1/parathyroid hormone axis. | The Prostate 20100201 |
| [Evaluation of pain reduction upon injecting goserelin acetate using an ice pack]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100201 |
| Is biochemical response more important than duration of neoadjuvant hormone therapy before radiotherapy for clinically localized prostate cancer? An analysis of the 3- versus 8-month randomized trial. | International journal of radiation oncology, biology, physics 20100101 |
| Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial. | BJU international 20100101 |
| [A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100101 |
| Final report on low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer. | Aktuelle Urologie 20100101 |
| Recent case developments in health law. Pharmaceutical price-fixing and consumer protection: Blue Cross & Blue Shield v. AstraZeneca Pharmaceuticals LP. | The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 20100101 |
| Results of the Zometa cost-utility model for the german healthcare system based on the results of the ABCSG-12 study. | Onkologie 20100101 |
| [Modern tendencies in treatment of atypical glandular hyperplasia--our and foreign experience]. | Akusherstvo i ginekologiia 20100101 |
| Reinduction of hormone sensitivity to goserelin following chemotherapy with vinorelbine in castration-resistant prostate cancer. | TheScientificWorldJournal 20100101 |
| [¹⁸F-FDG PET-CT in cytomegalovirus-induced mononucleosis]. | Revista espanola de medicina nuclear 20100101 |
| Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor. | Medical oncology (Northwood, London, England) 20091201 |
| The effect of concurrent androgen deprivation and 3D conformal radiotherapy on prostate volume and clinical organ doses during treatment for prostate cancer. | The British journal of radiology 20091201 |
| Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience. | BJU international 20091101 |
| Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain. | BJOG : an international journal of obstetrics and gynaecology 20091101 |
| [A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| Sexual dysfunction and aromatase inhibitor use in survivors of breast cancer. | Clinical breast cancer 20091101 |
| LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. | The Cochrane database of systematic reviews 20091007 |
| Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. | Breast cancer research and treatment 20091001 |
| A 16-year clinical experience with intermittent androgen deprivation for prostate cancer: oncological results. | World journal of urology 20091001 |
| [Catamenial pneumothorax with breast cancer treated successfully by goserelin acetate]. | Kyobu geka. The Japanese journal of thoracic surgery 20091001 |
| Short term results from GHRH analogue use in pre-menopausal breast cancer in Korea. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20090901 |
| Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy. | International journal of radiation oncology, biology, physics 20090901 |
| Subdural collections arising from calvarial metastases following discontinuation of anti-angiogenic therapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20090901 |
| Androgen deprivation therapy regulation of beta1C integrin expression in prostate cancer. | Oncology reports 20090801 |
| Questioning GnRH analogs for gonadal protection in cancer patients. | Fertility and sterility 20090801 |
| GnRH analogue for chemotherapy-induced ovarian damage: too early to say? | Fertility and sterility 20090801 |
| [Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis]. | Zhonghua fu chan ke za zhi 20090701 |
| Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer. | Psycho-oncology 20090601 |
| Endocrine therapy plus zoledronic acid in premenopausal breast cancer. | The New England journal of medicine 20090528 |
| Endocrine therapy plus zoledronic acid in premenopausal breast cancer. | The New England journal of medicine 20090528 |
| Endocrine therapy plus zoledronic acid in premenopausal breast cancer. | The New England journal of medicine 20090528 |
| Endocrine therapy plus zoledronic acid in premenopausal breast cancer. | The New England journal of medicine 20090528 |
| Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090520 |
| Initial growth deceleration during GnRH analogue therapy for precocious puberty. | Clinical endocrinology 20090501 |
| Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study. | European journal of obstetrics, gynecology, and reproductive biology 20090501 |
| Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090501 |
| Novel insights into GnRH receptor activity: role in the control of human glioblastoma cell proliferation. | Oncology reports 20090501 |
| Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy. | BJOG : an international journal of obstetrics and gynaecology 20090401 |
| Steroidal antiandrogen administration to treat gonadotropin-releasing hormone analogue-induced orchialgia. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20090401 |
| Alcohol as a potential contributing factor in radiation complications. | Clinical advances in hematology & oncology : H&O 20090401 |
| Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer. | Journal of the National Cancer Institute 20090304 |
| Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. | Fertility and sterility 20090301 |
| A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation. | The Journal of urology 20090301 |
| Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial. | Journal of the National Cancer Institute 20090218 |
| Endocrine therapy plus zoledronic acid in premenopausal breast cancer. | The New England journal of medicine 20090212 |
| Short term effects of GnRH agonists on plasma fibrinolytic balance in patients with advanced prostate cancer. | Journal of thrombosis and thrombolysis 20090201 |
| Pretreatment with gonadotropin-releasing hormone (GnRH) antagonists to prevent the flare-up effect of long-acting GnRH agonists: results of a pilot study. | Fertility and sterility 20090201 |
| Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer. | International journal of radiation oncology, biology, physics 20090201 |
| Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: results from a Canadian randomized trial. | Cancer 20090201 |
| Effect of luteinizing hormone-releasing hormone agonists on behavior in a patient with dementia. | Journal of clinical psychopharmacology 20090201 |
| Androgen deprivation therapy for patients with prostate carcinoma and Parkinson's disease: case report and review of literature. | The Canadian journal of urology 20090201 |
| Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience. | Breast cancer research and treatment 20090101 |
| Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report. | Archives of gynecology and obstetrics 20090101 |
| Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976-2005. | Acta oncologica (Stockholm, Sweden) 20090101 |
| Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090101 |
| Neoadjuvant hormonal deprivation for patients undergoing radical prostatectomy. | Asian journal of andrology 20090101 |
| Aggressive angiomyxoma of the vulva: a case report and review of the literature. | Journal of lower genital tract disease 20090101 |
| Effect of androgen suppression compared with androgen receptor blockade on arterial stiffness in men with prostate cancer. | Journal of andrology 20090101 |
| Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations. | Oncology (Williston Park, N.Y.) 20090101 |
| Adjuvant endocrine therapy for premenopausal hormone receptor-positive breast cancer; much done, more to do. | Oncology (Williston Park, N.Y.) 20090101 |
| Expanding role of ovarian suppression/ablation in premenopausal ER-positive breast cancer: issues and opportunities. | Oncology (Williston Park, N.Y.) 20090101 |
| Benefit of whole pelvic radiotherapy combined with neoadjuvant androgen deprivation for the high-risk prostate cancer. | Journal of biomedicine & biotechnology 20090101 |
| Long-term survival and PSA control with radiation and immunotherapy for node positive prostate cancer. | Clinical & developmental immunology 20090101 |
| Anaemia following initiation of androgen deprivation therapy for metastatic prostate cancer: a retrospective chart review. | The aging male : the official journal of the International Society for the Study of the Aging Male 20081201 |
| Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer. | The Journal of rheumatology 20081201 |
| Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081020 |
| LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. | The Cochrane database of systematic reviews 20081008 |
| Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02. | European urology 20081001 |
| Editorial comment on: Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02. | European urology 20081001 |
| Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer. | The Journal of urology 20081001 |
| Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080910 |
| Undetectable level of prostate specific antigen (PSA) nadir predicts PSA biochemical failure in local prostate cancer with delayed-combined androgen blockade. | Japanese journal of clinical oncology 20080901 |
| Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. | The Lancet. Oncology 20080901 |
| Endometriosis can evade diagnosis. | RN 20080901 |
| Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC). | Breast cancer research and treatment 20080801 |
| Effect of medical castration on CYP3A4 enzyme activity using the erythromycin breath test. | Cancer chemotherapy and pharmacology 20080801 |
| Chorea induced by a luteinizing hormone-releasing hormone analog. | Journal of neurology 20080801 |
| Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity. | International journal of oncology 20080801 |
| Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles. | Journal of Korean medical science 20080801 |
| Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy? | Annals of oncology : official journal of the European Society for Medical Oncology 20080701 |
| The difficult decision-making process for using or not using adjuvant chemotherapy in premenopausal endocrine-responsive breast cancer patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20080701 |
| Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs. | The Journal of clinical endocrinology and metabolism 20080701 |
| [Quality of life following endocrine therapy for advanced prostate cancer: a comparative study between LH-RH agonist 1-month depot and 3-month depot]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20080701 |
| Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080620 |
| Serum testosterone recovery after cessation of long-term luteinizing hormone-releasing hormone agonist in patients with prostate cancer. | Urology 20080601 |
| A study of visuospatial working memory pre- and post-Gonadotropin Hormone Releasing Hormone agonists (GnRHa) in young women. | Hormones and behavior 20080601 |
| [Guide to the treatment and care of lymphangioleiomyomatosis]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20080601 |
| Goserelin-induced transient thyrotoxicosis in a hypothyroid woman on L-thyroxine replacement. | The Netherlands journal of medicine 20080601 |
| Goserelin versus leuprolide before hysterectomy for uterine fibroids. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20080501 |
| Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer. | BJU international 20080501 |
| p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20080401 |
| A simple step to improve patient adherence with Zoladex. | Clinical journal of oncology nursing 20080401 |
| Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080320 |
| Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080320 |
| Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080315 |
| [The administration of goserelin and the nursing role during injections visits]. | Soins; la revue de reference infirmiere 20080301 |
| Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080215 |
| Efficacy of tibolone as 'add-back therapy' in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids. | Fertility and sterility 20080201 |
| Synthesis and characterization of biodegradable networks providing saturated-solution prolonged delivery. | Journal of pharmaceutical sciences 20080201 |
| Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02. | International journal of radiation oncology, biology, physics 20080201 |
| Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080201 |
| Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer. | Prostate cancer and prostatic diseases 20080101 |
| Anti-androgens increase N-terminal pro-BNP levels in men with prostate cancer. | Clinical endocrinology 20080101 |
| Expression level of beta protein 1 mRNA in Chinese breast cancer patients: a potential molecular marker for poor prognosis. | Cancer science 20080101 |
| CE hydrogen deuterium exchange-MS in peptide analysis. | Electrophoresis 20080101 |
| Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity. | Urologic oncology 20080101 |
| Evaluation of resistance index in patients with prostate cancer. | Anticancer research 20080101 |
| Unusual presentation of prostate cancer with generalized lymphadenopathy and unilateral leg edema. | JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR) 20080101 |
| Effects of voluntary wheel running on cardiac function and myosin heavy chain in chemically gonadectomized rats. | American journal of physiology. Heart and circulatory physiology 20071201 |
| A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission. | Cancer 20071201 |
| A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. | Neoplasia (New York, N.Y.) 20071201 |
| Leuprorelin, triptorelin: new indications. Locally advanced prostate cancer: minimally assessed me-toos. | Prescrire international 20071201 |
| A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women. | European journal of obstetrics, gynecology, and reproductive biology 20071101 |
| A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer - GABG-IV B-93. | European journal of cancer (Oxford, England : 1990) 20071101 |
| Precocious puberty in Turner syndrome. | Journal of paediatrics and child health 20071101 |
| Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy. | Cancer 20071015 |
| The change in the dihydrotestosterone level in the prostate before and after androgen deprivation therapy in connection with prostate cancer aggressiveness using the Gleason score. | The Journal of urology 20071001 |
| Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference. | The Lancet. Oncology 20071001 |
| Current status of endocrine therapy for prostate cancer in Japan analysis of primary androgen deprivation therapy on the basis of data collected by J-CaP. | Japanese journal of clinical oncology 20071001 |
| [Skin reaction induced by subcutaneous injection of LH-RH analogue]. | Hinyokika kiyo. Acta urologica Japonica 20071001 |
| Cellular changes in prostate cancer cells induced by intermittent androgen suppression. | European urology 20070901 |
| Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial. | International journal of radiation oncology, biology, physics 20070901 |
| [Solitary peritoneal carcinomatosis in prostate cancer]. | Aktuelle Urologie 20070901 |
| Role of gonadotropin-releasing hormone analog in the management of male metastatic breast cancer is uncertain. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070820 |
| Bone density in breast cancer: when to intervene? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070801 |
| Injection-site granulomas resulting from the administration of both leuprorelin acetate and goserelin acetate for the treatment of prostatic cancer. | Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20070801 |
| Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial. | Clinical therapeutics 20070801 |
| Hormonal therapy of endometrial stromal sarcoma. | Current opinion in oncology 20070701 |
| Gonadotrophin releasing hormone analogues for the management of placenta accreta: A novel concept. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20070701 |
| Incidence rate of injection-site granulomas resulting from the administration of luteinizing hormone-releasing hormone analogues for the treatment of prostatic cancer. | Yonsei medical journal 20070630 |
| [Hormone therapy for breast cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20070628 |
| Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. | Lancet (London, England) 20070519 |
| Quantification of buserelin in a pharmaceutical product by multiple-injection CZE. | Electrophoresis 20070501 |
| Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070501 |
| Could bone tissue be a target for luteinizing hormone/chorionic gonadotropin? | Molecular and cellular endocrinology 20070415 |
| Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial. | Journal of the National Cancer Institute 20070404 |
| Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men. | Bone 20070401 |
| Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070301 |
| [Study on the administration of goserelin. Methodology and results]. | Soins; la revue de reference infirmiere 20070301 |
| Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy. | International journal of urology : official journal of the Japanese Urological Association 20070301 |
| Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer. | International journal of urology : official journal of the Japanese Urological Association 20070301 |
| Neoadjuvant endocrine therapy in breast cancer. | Cancer treatment reviews 20070201 |
| Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. | Cancer 20070201 |
| Goserelin acetate in combination with radiotherapy for prostate cancer. | Expert opinion on pharmacotherapy 20070201 |
| [Giant prostate carcinoma treated effectively with endocrine therapy: case report]. | Hinyokika kiyo. Acta urologica Japonica 20070201 |
| Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070120 |
| Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans. | The Journal of physiology 20070115 |
| Minimal invasive treatment of vesicouterine fistula: a case report. | International urology and nephrology 20070101 |
| Penile length changes in men treated with androgen suppression plus radiation therapy for local or locally advanced prostate cancer. | The Journal of urology 20070101 |
| Luteinizing hormone release after administration of the gonadotropin-releasing hormone agonist Fertilan (goserelin) for synchronization of ovulation in pigs. | Journal of animal science 20070101 |
| Bicalutamide 80 mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randomized, double-blind, multicenter trial in Japanese patients. | Prostate cancer and prostatic diseases 20070101 |
| Luteinizing hormone-releasing hormone analogue-induced cataract in a patient with prostate cancer. | Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20070101 |
| Efficacy of a monthly compared to 3-monthly depot GnRH analogue (goserelin) in the treatment of children with central precocious puberty. | Hormone research 20070101 |
| Goserelin administration causing an acute abdomen in a patient with a fibroid uterus. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20070101 |
| Endocrine response to a single injection of goserelin 3.6 mg or leuprolide 3.75 mg in men with prostate cancer. | Archives of andrology 20070101 |
| Recent perspectives of endocrine therapy for breast cancer. | Breast cancer (Tokyo, Japan) 20070101 |
| Effects of acute ovarian hormone suppression on the human brain: an in vivo 1H MRS study. | Psychoneuroendocrinology 20070101 |
| Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate. | Acta oncologica (Stockholm, Sweden) 20070101 |
| Neuroendocrine differentiation of localized prostate cancer during endocrine therapy. | Scandinavian journal of urology and nephrology 20070101 |
| Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. | Psychoneuroendocrinology 20070101 |
| Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study. | American journal of physiology. Endocrinology and metabolism 20061201 |
| Recurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: case report and review of the literature. | Pharmacotherapy 20061201 |
| Treatment of dysfunctional uterine bleeding in the perimenopause: the effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment--a randomized, placebo-controlled, double-blind trial. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20061201 |
| Fertility preservation in (breast) cancer patients: is it safe? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061120 |
| Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate. | Fertility and sterility 20061101 |
| Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues. | Journal of pediatric endocrinology & metabolism : JPEM 20061101 |
| Catamenial pneumothorax: surgical repair of the diaphragm and hormone treatment. | Annals of the Royal College of Surgeons of England 20061001 |
| Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression. | Urology 20061001 |
| Apoplexy of clinically silent pituitary adenoma during prostate cancer treatment with LHRH analog. | Neuro endocrinology letters 20061001 |
| [Breast cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20060928 |
| Bilateral orchidectomy in three metastatic prostate cancer patients with failed LHRH-agonist therapy. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20060901 |
| CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93). | European journal of cancer (Oxford, England : 1990) 20060801 |
| Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth. | The Journal of urology 20060701 |
| Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancer. | Journal of the National Medical Association 20060701 |
| [8-month neoadjuvant hormonal therapy before radical prostatectomy for high-risk prostate cancer]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20060701 |
| Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study. | European journal of cancer (Oxford, England : 1990) 20060501 |
| Administration of goserelin acetate after uterine artery embolization does not change the reduction rate and volume of uterine myomas. | Fertility and sterility 20060501 |
| Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms? | Urology 20060501 |
| Aromatase inhibitor withdrawal response in metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060420 |
| [An outline of GnRH analogue]. | Nihon rinsho. Japanese journal of clinical medicine 20060401 |
| [Clinical applications of GnRHa in breast cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20060401 |
| [Prostate cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20060401 |
| Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10. | International journal of radiation oncology, biology, physics 20060315 |
| Aggressive angiomyxoma of the vulva: Dramatic response to gonadotropin-releasing hormone agonist therapy. | Gynecologic oncology 20060301 |
| Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer. | BJU international 20060301 |
| Effects on the male endocrine system of long-term treatment with gonadotropin-releasing hormone agonists and estrogens in male-to-female transsexuals. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20060301 |
| Influence of number of CAG repeats on local control in the RTOG 86-10 protocol. | American journal of clinical oncology 20060201 |
| Goserelin for menstrual psychosis. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20060201 |
| [Two cases of stage IV breast cancer with severe hypercalcemia]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060201 |
| Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20060101 |
| Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma. | Cancer 20060101 |
| Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. | The Journal of urology 20060101 |
| Goserelin. | Nursing times 20060101 |
| Enhanced expression of heat shock protein 27 following neoadjuvant hormonal therapy is associated with poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer. | Anticancer research 20060101 |
| [Hysteroresection of submucous myomas after treatment with zoladex]. | Akusherstvo i ginekologiia 20060101 |
| [Pregnancy after treatment of primary sterility with zoladex in patient with essential thrombocytopenia]. | Akusherstvo i ginekologiia 20060101 |
| Molecular markers and their prognostic impact in patients with advanced prostate cancer undergoing intermittent androgen suppression. | Prostate cancer and prostatic diseases 20060101 |
| Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group. | Anticancer research 20060101 |
| Androgen deprivation therapy and cardiac function: effects of endurance training. | Prostate cancer and prostatic diseases 20060101 |
| Goserelin-induced new-onset depressive disorder. | Psychosomatics 20060101 |
| The limited significance of a longer duration of neoadjuvant hormonal therapy prior to radical prostatectomy for high-risk prostate cancer in Japanese men. | Urologia internationalis 20060101 |
| [Using GnRH-agonists (Zoladex) in the treatment of genital endometriosis]. | Akusherstvo i ginekologiia 20060101 |
| Choroidal metastasis in a patient with disseminated breast cancer: hormonal therapy-induced regression. | The breast journal 20060101 |
| [The enigma of desmoid fibroma]. | Voprosy onkologii 20060101 |
| The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer. | International urology and nephrology 20060101 |
| Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer. | Anticancer research 20060101 |
| Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. | International journal of radiation oncology, biology, physics 20051201 |
| The biology of steroid hormones and endocrine treatment of breast cancer. | Breast (Edinburgh, Scotland) 20051201 |
| Re: A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy. | The Journal of urology 20051201 |
| Injection systems for two luteinising hormone-releasing hormone agonists: a comparative assessment of administration times and nurses' perceptions. | European journal of oncology nursing : the official journal of European Oncology Nursing Society 20051201 |
| [Assessment of goserelin treatment in adjuvant therapy for premenopausal patients with breast cancer in Japan-zoladex breast cancer study group trial-B]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051201 |
| Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. | The Lancet. Oncology 20051101 |
| [Are all LH-RH analogues equally effective in prostate cancer?]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20050922 |
| Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer. | British journal of cancer 20050919 |
| Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901 |
| Late radiotherapy toxicity after prostate cancer treatment: influence of hormonal therapy. | Urology 20050901 |
| What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? | The Lancet. Oncology 20050801 |
| Use of goserelin in the treatment of breast cancer. | Expert review of anticancer therapy 20050801 |
| RTOG study shows improved survival for prostate cancer patients given adjuvant goserelin. | Oncology (Williston Park, N.Y.) 20050801 |
| Successful hormone treatment of orbital leiomyoma. | Ophthalmology 20050701 |
| Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. | BJU international 20050701 |
| PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. | European urology 20050701 |
| [Adjuvant chemotherapy of premenopausal breast cancer with LH-RH analogue for ovarian protection--a case report]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050701 |
| The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20050601 |
| Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report. | International psychogeriatrics 20050601 |
| Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20050601 |
| A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy. | The Journal of urology 20050501 |
| [Reevaluation of MAB therapy and progress of endocrine therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050501 |
| Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050501 |
| Docetaxel followed by hormone therapy in men experiencing increasing prostate-specific antigen after primary local treatments for prostate cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050420 |
| Controlled release of goserelin from microporous polyglycolide and polylactide. | Macromolecular bioscience 20050419 |
| Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. | Cancer 20050415 |
| The effect of physical training on bone mineral density in women with endometriosis treated with GnRH analogs: a pilot study. | Acta obstetricia et gynecologica Scandinavica 20050401 |
| Testosterone recovery and changes in bone mineral density after stopping long-term luteinizing hormone-releasing hormone analogue therapy in osteoporotic patients with prostate cancer. | BJU international 20050401 |
| Final adult height and body mass index after cure of paediatric Cushing's disease. | Clinical endocrinology 20050401 |
| Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31. | International journal of radiation oncology, biology, physics 20050401 |
| Endometrial resection and preoperative LH-RH agonists: a prospective 5-year trial. | European journal of obstetrics, gynecology, and reproductive biology 20050301 |
| Zoledronic acid prevents cancer treatment-induced bone loss. | Oncology (Williston Park, N.Y.) 20050301 |
| Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050220 |
| A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. | British journal of cancer 20050214 |
| Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201 |
| [Hormonal therapy for prostatic cancer--state of the art]. | Nihon rinsho. Japanese journal of clinical medicine 20050201 |
| Disorders in cytokine gene expression in endometrial hyperplasia and effect of hormone therapy. | Bulletin of experimental biology and medicine 20050201 |
| Oestrogen-selective modulation of FSH and LH secretion by pituitary gland. | British journal of cancer 20050131 |
| Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy. | Cancer 20050115 |
| Hormonal therapy for primary breast cancer: scientific rationale and status of clinical research. | Current oncology reports 20050101 |
| Randomized controlled trial to evaluate radiotherapy +/- endocrine therapy versus endocrine therapy alone for PSA failure after radical prostatectomy: Japan Clinical Oncology Group Study JCOG 0401. | Japanese journal of clinical oncology 20050101 |
| Does needle size matter? Patient experience of luteinising hormone-releasing hormone analogue injection. | Prostate cancer and prostatic diseases 20050101 |
| Bicalutamide vs cyproterone acetate in preventing flare with LHRH analogue therapy for prostate cancer--a pilot study. | Prostate cancer and prostatic diseases 20050101 |
| [Gynecological laparscopy, endometriosis and sterility]. | Akusherstvo i ginekologiia 20050101 |
| Impact of hormone therapy on acute radiotherapy toxicity in the treatment of prostate cancer. | Prostate cancer and prostatic diseases 20050101 |
| Response of T lymphocyte populations in prostate cancer patients undergoing radiotherapy: influence of neoajuvant total androgen suppression. | Anticancer research 20050101 |
| Gonadotropin-releasing hormone agonists for the management of ovarian cysts in menopause breast cancer patients on tamoxifen treatment. | The breast journal 20050101 |
| [Drawbacks of ovarian ablation with goserelin in women with breast cancer]. | Acta medica portuguesa 20050101 |
| Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer? | Nature clinical practice. Oncology 20050101 |
| The role of ovarian ablation in the management of breast cancer. | The breast journal 20050101 |
| Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women. | Drugs 20050101 |
| Release of vasopressin during suppression of oestrous cycle in rat by zoladex and hypovolemic challenge. | Journal of Ayub Medical College, Abbottabad : JAMC 20050101 |
| European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia. | American journal of obstetrics and gynecology 20041201 |
| Similar frequency of testosterone surge after repeat injections of goserelin (Zoladex) 3.6 mg and 10.8 mg: results of a randomized open-label trial. | Urology 20041201 |
| Same gain, less pain: potential patient preferences for adjuvant treatment in premenopausal women with early breast cancer. | European journal of cancer (Oxford, England : 1990) 20041101 |
| Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. | Clinical endocrinology 20041101 |
| Comparative study of different dosages of goserelin in size reduction of myomatous uteri. | The Journal of the American Association of Gynecologic Laparoscopists 20041101 |
| Suppression of a postmenopausal ovarian cyst with goserelin. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20041101 |
| Novel targets for the treatment of endometriosis. | Expert opinion on therapeutic targets 20041001 |
| Unexpected response of hormone-refractory prostate cancer to treatment with an antileukemic chemotherapy regimen. | Urology 20041001 |
| [Postoperative changes in serum lipid levels of breast cancer and adjuvant chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20041001 |
| Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040915 |
| Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III study. | The Journal of urology 20040901 |
| Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer. | International journal of radiation oncology, biology, physics 20040901 |
| 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. | JAMA 20040818 |
| Osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy. | The Journal of urology 20040801 |
| Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancer. | Urology 20040701 |
| Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. | BJU international 20040501 |
| Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade. | The Journal of urology 20040401 |
| Adjuvant endocrine therapy. | Best practice & research. Clinical endocrinology & metabolism 20040301 |
| Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer. | British journal of cancer 20040209 |
| Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study. | Journal of surgical oncology 20040201 |
| [A case of seminal vesicle cyst due to the obstruction of the ejaculatory duct: possible association with prostate cancer]. | Hinyokika kiyo. Acta urologica Japonica 20040201 |
| Dynamic contrast enhanced magnetic resonance imaging in monitoring bone metastases in breast cancer patients receiving bisphosphonates and endocrine therapy. | Acta radiologica (Stockholm, Sweden : 1987) 20040201 |
| Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT. | Cancer 20040115 |
| Prognosis of stage pT0 after prolonged neoadjuvant endocrine therapy of prostate cancer: a matched-pair analysis. | European urology 20040101 |
| Adjuvant goserelin improves clinical disease-free survival and reduces disease-related mortality in patients with locally advanced or localized prostate cancer. | BJU international 20040101 |
| 8th Nottingham International Breast Cancer Conference, Nottingham, UK, 16-19 September 2003. | Breast cancer research : BCR 20040101 |
| The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. | Human reproduction (Oxford, England) 20040101 |
| Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. | The American journal of pathology 20040101 |
| Chemical ablation of endometrium with trichloroacetic acid. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20040101 |
| Women with breast cancer opt for treatment with minimal side-effects. | The Lancet. Oncology 20040101 |
| Radiotherapy in cT3 prostatic carcinoma: retrospective comparison between neoadjuvant and adjuvant hormonotherapy. | Urologia internationalis 20040101 |
| Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Japanese patients. | Japanese journal of clinical oncology 20040101 |
| High-dose radiotherapy plus prolonged hormone therapy in CT2-3 prostatic carcinoma: is it useful? | Tumori 20040101 |
| The effect of prostate cancer and antiandrogenic therapy on lipid peroxidation and antioxidant systems. | International urology and nephrology 20040101 |
| Effect of primary anthracycline-based chemotherapy on disseminated tumor cells in locally advanced breast cancer. | Anticancer research 20040101 |
| Central pain and complex motoric symptoms after gosarelin therapy of prostate cancer. | TheScientificWorldJournal 20040101 |
| Goserelin ('Zoladex')--offering patients more choice in early breast cancer. | European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101 |
| [Endometriosis during postmenopausal period--probable causes for its origin and development]. | Akusherstvo i ginekologiia 20040101 |
| Prostate volume before and after permanent prostate brachytherapy in patients receiving neoadjuvant androgen suppression. | Cancer journal (Sudbury, Mass.) 20040101 |
| Ovarian ablation as adjuvant therapy for premenopausal women with breast cancer--another step forward. | Journal of the National Cancer Institute 20031217 |
| Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. | Journal of the National Cancer Institute 20031217 |
| Reversible ovarian ablation or chemotherapy: are we ready for quality of life to guide adjuvant treatment decisions in breast cancer? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031215 |
| Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031215 |
| Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF). | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20031201 |
| Profiling and in vivo quantification of proteins by high resolution mass spectrometry: the example of goserelin, an analogue of luteinizing hormone-releasing hormone. | Clinical chemistry and laboratory medicine 20031201 |
| [Progress in researches on drugs for prostate cancer]. | Zhonghua nan ke xue = National journal of andrology 20031201 |
| Intermittent maximal androgen blockade in patients with metastatic prostate cancer: an EORTC feasibility study. | European urology 20031101 |
| Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031101 |
| High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031001 |
| Effects of goserelin administration before myomectomy on plasma homocysteine levels in patients with symptomatic uterine leiomyomata. | Fertility and sterility 20031001 |
| Unusual morphologic features of uterine leiomyomas treated with gonadotropin-releasing hormone agonists: massive lymphoid infiltration and vasculitis. | International journal of surgical pathology 20031001 |
| Meeting the needs of younger women with breast cancer. | Nursing times 20031001 |
| Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles--a prospective, randomized study. | Reproductive biomedicine online 20031001 |
| [Effect of combined surgical and pharmacologic treatment on peripheral blood cytokine concentrations in women with endometriosis]. | Ginekologia polska 20031001 |
| Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20030901 |
| Is bicalutamide equivalent to goserelin for prostate volume reduction before radiation therapy? A prospective, observational study. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20030901 |
| Highlights from the 39th Annual meeting of the American Society of Clinical Oncology Chicago, Illinois. | Clinical prostate cancer 20030901 |
| Correlations in the cytokine system in endometrial hyperplasia. | Bulletin of experimental biology and medicine 20030901 |
| Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer. | European journal of cancer (Oxford, England : 1990) 20030801 |
| Impact of hormone therapy when combined with external beam radiotherapy for early-stage, intermediate-, or high-risk prostate cancer. | American journal of clinical oncology 20030801 |
| Histological classification of endometriosis as a predictor of response to treatment. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20030701 |
| Can endocrine treatment for hormone-positive premenopausal women with early breast cancer replace adjuvant chemotherapy? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615 |
| Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet! | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615 |
| Combined endocrine blockade in premenopausal breast cancer: a superior therapeutic option for adjuvant management? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615 |
| The comparison of clinical and hormonal parameters in PCOS patients treated with metformin and GnRH analogue. | Archives of gynecology and obstetrics 20030601 |
| A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy. | Fertility and sterility 20030601 |
| The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis. | Mediators of inflammation 20030601 |
| Rotational 3D-conformal radiation therapy (conformation therapy) combined with hormone therapy for the treatment of stage B2/C prostate cancer in Japanese men. | International journal of radiation oncology, biology, physics 20030501 |
| GnRH analogues as an adjuvant therapy for ovarian cancer patients. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20030501 |
| The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women. | European journal of cancer (Oxford, England : 1990) 20030501 |
| Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030501 |
| Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. | Headache 20030401 |
| Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030401 |
| Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure. | Acta obstetricia et gynecologica Scandinavica 20030401 |
| Acute goserelin administration inhibits gonadotropin and androgen secretion in post-menopausal women with ovarian hyperandrogenism. | Journal of endocrinological investigation 20030301 |
| Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia. | Clinical science (London, England : 1979) 20030201 |
| Hormone-refractory prostate cancer responding to capecitabine. | Urology 20030201 |
| Eligard: leuprolide acetate in a novel sustained-release delivery system. | Urology 20030201 |
| Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials. | The Journal of urology 20030101 |
| Health related quality of life using serum testosterone as the trigger to re-dose long acting depot luteinizing hormone-releasing hormone agonists in patients with prostate cancer. | The Journal of urology 20030101 |
| Differential effects of androgens and estrogens on bone turnover in normal men. | The Journal of clinical endocrinology and metabolism 20030101 |
| Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose. | Acta oncologica (Stockholm, Sweden) 20030101 |
| Current status of endocrine therapy for breast cancer. | Breast cancer (Tokyo, Japan) 20030101 |
| 3-month formulation of goserelin acetate ('Zoladex' 10.8-mg depot) in advanced prostate cancer: results from an Italian, open, multicenter trial. | Urologia internationalis 20030101 |
| Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS. | Gynecologic and obstetric investigation 20030101 |
| Randomised crossover trial to assess the tolerability of LHRH analogue administration. | Prostate cancer and prostatic diseases 20030101 |
| A cost-outcome analysis of long-term adjuvant goserelin in addition to radiotherapy for locally advanced prostate cancer. | Urologic oncology 20030101 |
| mRNA-expression of often used house-keeping genes and the relation between RNA and DNA are sex steroid-dependent parameters in human myometrium and fibroids. | Gynecologic and obstetric investigation 20030101 |
| Neoadjuvant hormonal treatment and radiotherapy for prostate cancer. | Oncology 20030101 |
| AstraZeneca to pay $355 million fine. | FDA consumer 20030101 |
| Focus on anastrozole and breast cancer. | Current medical research and opinion 20030101 |
| Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021215 |
| Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021215 |
| Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: a secondary analysis of the randomized protocol RTOG 86-10. | International journal of radiation oncology, biology, physics 20021201 |
| Luteinising hormone releasing hormone analogues in the treatment of prostate cancer. | Expert opinion on pharmacotherapy 20021201 |
| Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study. | American journal of clinical oncology 20021201 |
| [Characteristics, effects, side effects of the LH-RH agonist]. | Nihon rinsho. Japanese journal of clinical medicine 20021201 |
| [Time to normalization of testosterone after withdrawal of long time LH-RH agonist therapy in prostate cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20021201 |
| [Total androgen blockade]. | Nihon rinsho. Japanese journal of clinical medicine 20021201 |
| [The trends in new drugs for the prostate cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20021201 |
| Testosterone suppression in men with prostate cancer is associated with increased arterial stiffness. | The aging male : the official journal of the International Society for the Study of the Aging Male 20021201 |
| Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial. | Clinical prostate cancer 20021201 |
| Cutaneous endometriosis: a combination of medical and surgical treatment. | The Journal of dermatological treatment 20021201 |
| Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy. | International journal of radiation oncology, biology, physics 20021115 |
| In regard to Padula et al., normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. IJROBP 2002;52: 439-443. | International journal of radiation oncology, biology, physics 20021101 |
| Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109. | The Journal of urology 20021101 |
| Role of LHRH agonists in premenopausal women with oestrogen receptor-positive breast cancer: the ZEBRA experience. | European journal of cancer (Oxford, England : 1990) 20021101 |
| Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue. | Fertility and sterility 20021101 |
| Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: updated results of a multicentric trial. | European urology 20021101 |
| Overview of luteinizing hormone-releasing hormone agonists in early breast cancer-benefits of reversible ovarian ablation. | Breast cancer research and treatment 20021001 |
| Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. | Fertility and sterility 20021001 |
| Management of premenopausal women with early-stage breast cancer: is there a role for ovarian suppression? | Clinical breast cancer 20021001 |
| Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. | BJU international 20020901 |
| Unilateral autonomous testicular testosterone production mimicking androgen independent prostate cancer. | The Journal of urology 20020901 |
| Improved prostate cancer treatment. | Health news (Waltham, Mass.) 20020901 |
| Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer. | Urology 20020901 |
| [A new LH-RH agonist for treatment of prostate cancer, 3-month controlled-release formulation of goserelin acetate (Zoladex LA 10.8 mg depot)--outline of pre-clinical and clinical studies]. | Gan to kagaku ryoho. Cancer & chemotherapy 20020901 |
| Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle. | Clinical endocrinology 20020801 |
| Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. | The Journal of clinical endocrinology and metabolism 20020801 |
| Locally expressed LHRH receptors mediate the oncostatic and antimetastatic activity of LHRH agonists on melanoma cells. | The Journal of clinical endocrinology and metabolism 20020801 |
| Treating relapsed epithelial ovarian cancer with luteinizing hormone-releasing agonist (goserelin) after failure of chemotherapy. | The Israel Medical Association journal : IMAJ 20020801 |
| Hormonal therapy of prostate cancer. | Seminars in urologic oncology 20020801 |
| Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter study. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20020801 |
| [Ovarian suppression in the adjuvant treatment of breast cancer: GnRh analogs, ovariectomy or radio-castration--'the philosopher's stone' instead of 'chamber of horrors']. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20020801 |
| [Prostatic cancer with multiple pulmonary metastases treated successfully with hormonal therapy: a case report]. | Hinyokika kiyo. Acta urologica Japonica 20020801 |
| Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. | Lancet (London, England) 20020713 |
| Resistance to luteinizing hormone releasing hormone agonist therapy for metastatic prostate cancer. | The Journal of urology 20020701 |
| Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. | International journal of radiation oncology, biology, physics 20020701 |
| Effect of local heating of rat testes after suppression of spermatogenesis by pretreatment with a GnRH agonist and an anti-androgen. | Reproduction (Cambridge, England) 20020701 |
| Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer? | Urology 20020701 |
| Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer. | Journal of clinical pathology 20020701 |
| Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response. | Journal of assisted reproduction and genetics 20020701 |
| Re: All-cause mortality in randomized trials of cancer screening. | Journal of the National Cancer Institute 20020605 |
| Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. | The Journal of urology 20020601 |
| Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium. | Fertility and sterility 20020601 |
| Prostate cancer: risk categories and role of hormones and radiotherapy. | The Canadian journal of urology 20020601 |
| Neoadjuvant androgen withdrawal prior to external radiotherapy for locally advanced adenocarcinoma of the prostate. | International journal of urology : official journal of the Japanese Urological Association 20020601 |
| Superovulation using recombinant human FSH and ultrasound-guided transabdominal follicular aspiration in baboon (Papio anubis). | Animal reproduction science 20020415 |
| Estimating survival gain for economic evaluations with survival time as principal endpoint: a cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer. | Health economics 20020401 |
| Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020401 |
| [Sustained complete response in lung metastasis of breast cancer by goserelin--report of two cases]. | Gan to kagaku ryoho. Cancer & chemotherapy 20020401 |
| Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study. | Anti-cancer drugs 20020401 |
| Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer. | British journal of cancer 20020304 |
| The influence of luteinizing hormone-releasing hormone analog on serum leptin and body composition in women with solitary uterine myoma. | American journal of obstetrics and gynecology 20020301 |
| Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. | British journal of cancer 20020212 |
| Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation. | International journal of radiation oncology, biology, physics 20020201 |
| Adjuvant hormone therapy in locally advanced and localized prostate cancer: three EORTC trials. | Frontiers of radiation therapy and oncology 20020101 |
| Fulvestrant: clinical application of an estrogen receptor downregulator. | Clinical therapeutics 20020101 |
| Direct effect of a gonadotropin-releasing hormone agonist on the growth of canine mammary tumour cells. | Journal of cellular biochemistry 20020101 |
| Hysteroscopic endometrial destruction, optimum method for preoperative endometrial preparation: a prospective, randomized, multicenter evaluation. | JSLS : Journal of the Society of Laparoendoscopic Surgeons 20020101 |
| Prostate-specific antigen dynamics predict risk of progression in advanced prostate cancer treated with bicalutamide plus castration. | Urologia internationalis 20020101 |
| [Hysteroscopic ablation of the endometrium in cases of dysfunctional uterine bleeding--advantage of preparations including zoladex]. | Akusherstvo i ginekologiia 20020101 |
| [Adjuvant therapy during the administration of GnRH agonists]. | Akusherstvo i ginekologiia 20020101 |
| Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding. | The Cochrane database of systematic reviews 20020101 |
| Severe symptomatic osteoporosis in patients on androgen deprivation therapy for prostatic carcinoma. | Scandinavian journal of urology and nephrology 20020101 |
| Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring. | Psycho-oncology 20020101 |
| Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss. | Prostate cancer and prostatic diseases 20020101 |
| Changes of resistance parameters of femoral bone in adult female rats after application of zoladex and vincristin. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20020101 |
| Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium. | Clinical science (London, England : 1979) 20011201 |
| Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20011201 |
| Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20011201 |
| Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20011201 |
| Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. | Radiology 20011101 |
| Goserelin (Zoladex)--its role in early breast cancer in pre- and perimenopausal women. | British journal of cancer 20011101 |
| A vision for the future? | British journal of cancer 20011101 |
| Treatment of an orchiectomized patient with hormone-refractory prostate cancer with LH-RH agonists. | European urology 20011001 |
| The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study. | Cancer 20010915 |
| FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation. | Nuclear medicine communications 20010901 |
| Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010901 |
| Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer: results decisively determined by the cut-off time-point chosen for the analysis. | European journal of cancer (Oxford, England : 1990) 20010901 |
| Persisting active and proliferative intrinsic ureteral endometriosis under GNRH agonists therapy: a case with immunohistological study. | European journal of obstetrics, gynecology, and reproductive biology 20010801 |
| Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. | International journal of radiation oncology, biology, physics 20010801 |
| Ureteric and pulmonary endometriosis. | Archives of gynecology and obstetrics 20010801 |
| [Intermittent androgen deprivation treatment of prostate cancer restarted at low level of serum prostate specific antigen: a pilot study]. | Hinyokika kiyo. Acta urologica Japonica 20010801 |
| Docetaxel followed by hormone therapy after failure of definitive treatments for clinically localized/locally advanced prostate cancer: preliminary results. | Seminars in oncology 20010801 |
| Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer. | International journal of cancer 20010720 |
| [Endocrine therapy for advanced or recurrent breast cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20010701 |
| Rapid onset of pituitary apoplexy after goserelin implant for prostate cancer: need for heightened awareness. | Internal medicine journal 20010701 |
| Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences. | The Prostate 20010615 |
| Spontaneous expulsion of a uterine submucosal leiomyoma after administration of a gonadotropin-releasing hormone agonist. | European journal of obstetrics, gynecology, and reproductive biology 20010601 |
| Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010601 |
| Endothelin-1 in human prostatic carcinoma treated with androgen withdrawal: an immunohistochemical study. | Cancer 20010515 |
| A randomized controlled trial of goserelin and medroxyprogesterone acetate in the treatment of pelvic congestion. | Human reproduction (Oxford, England) 20010501 |
| The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer. | The Journal of urology 20010501 |
| Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20010501 |
| [Clinical effects of a 3-month formulation LH-RH agonist (Zoladex LA 10.8 mg depot) in patients with prostate cancer]. | Hinyokika kiyo. Acta urologica Japonica 20010501 |
| [Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20010401 |
| Urinary excretion of calcitonin gene-related peptide in males with hot flushes after castration for carcinoma of the prostate. | Scandinavian journal of urology and nephrology 20010401 |
| Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. | International journal of radiation oncology, biology, physics 20010315 |
| Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy. | International journal of radiation oncology, biology, physics 20010315 |
| Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a 3-year follow-up evaluation. | Fertility and sterility 20010301 |
| Relationship between gonadotropin-releasing hormone agonist and myoma cellular activity: preliminary findings on positron emission tomography. | Fertility and sterility 20010301 |
| Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments? | Breast cancer research and treatment 20010301 |
| Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. | Radiology 20010201 |
| [Integrated (surgical and hormonal) treatment of advanced prostatic carcinoma. Comment on the study and the interview with Edward M. Messing]. | Recenti progressi in medicina 20010201 |
| [Update of the study on survival with early hormonal therapy associated with radiotherapy (EORTC 22863 Study) in patients with advanced prostatic cancer. Interview with Michel Bolla]. | Recenti progressi in medicina 20010201 |
| Inhibition of PSA flare in prostate cancer patients by administration of flutamide for 2 weeks before initiation of treatment with slow-releasing LH-RH agonist. | International journal of clinical oncology 20010201 |
| Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010115 |
| Biochemical markers for the detection of bone metastasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy. | Journal of bone and mineral metabolism 20010101 |
| Hormonal regulation of appetite and body mass in patients with advanced prostate cancer treated with combined androgen blockade. | Journal of endocrinological investigation 20010101 |
| [Successful complete androgen blockade (CAB) therapy for prostatic cancer detected from multiple lung metastases: a case report]. | Hinyokika kiyo. Acta urologica Japonica 20010101 |
| Goserelin (Zoladex) or orchiectomy in metastatic prostate cancer? A quality of life and cost-effectiveness analysis. | Anticancer research 20010101 |
| Treatment of localized prostate cancer with intermittent triple androgen blockade: preliminary results in 110 consecutive patients. | The oncologist 20010101 |
| [Adjuvant therapy of breast cancer]. | Khirurgiia 20010101 |
| Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101 |
| [Preliminary results of casodex use in patients with hormone-resistant cancer of the prostate]. | Urologiia (Moscow, Russia : 1999) 20010101 |
| Clinical efficacy of goserelin (Zoladex) in the treatment of uterine myomas in infertile patients. | Medicinski pregled 20010101 |
| Ovarian stimulation and ultrasound-guided oocyte retrieval in baboon (Papio Cynocephalus Anubis) during pituitary suppression with a GnRH agonist. | Acta veterinaria Hungarica 20010101 |
| The influence of cisplatinum and goserelinum on the magnesium and calcium level in rat serum. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20010101 |
| Controlled ovarian stimulation and ultrasound guided follicular aspiration in the baboon (Papio cynocephalus anubis). | Reproduction, nutrition, development 20010101 |
| The effects of GnRH analogues and antiandrogenes in preventing the gonadotoxic effects of COPP chemotherapy. | International urology and nephrology 20010101 |
| Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer--self-rated physiological effects and symptoms. | Acta oncologica (Stockholm, Sweden) 20000101 |
| Frequency of flutamide induced hepatotoxicity in patients with prostate carcinoma. | Human & experimental toxicology 19990301 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.